LTS LOHMANN Therapie-Systeme

LTS Lohmann Therapie-Systeme AG broke ground on a major expansion at its West St. Paul, Minnesota campus. The multi-year project includes $10 million already invested since 2024 and an additional $30 million planned through 2028, expanding R&D labs, pilot manufacturing, cleanrooms, and warehousing.

LTS LOHMANN Therapie-Systeme has successfully validated a semi-automated commercial production line for the Sorrel wearable drug delivery platform at its facility in Netanya, Israel. The company also announced plans to expand Sorrel production into Western markets.